Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy

Chathur Acharya, Sara McGeorge, Andrew Fagan, James B. Wade, Hannah Lee, Velimir Luketic, Richard K. Sterling, Leroy Thacker, Jasmohan S. Bajaj – 16 July 2022 – Driving is independently affected by cirrhosis and hepatic encephalopathy (HE) and alcohol/substance use, but their concomitant impact is unclear. We aimed to determine the impact of alcohol and other substances on driving‐simulator performance in cirrhosis with and without HE.

Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021

Saad Emhmed Ali, Philip Vutien, C. Andrew Bonham, Charles Landis, Paul Kwo, Carlos Esquivel, Mindie H. Nguyen – 16 July 2022 – The demand for orthotopic liver transplantation (OLT) is projected to increase, which indicates a need to expand the liver donor pool. We aimed to investigate the use of hepatitis B virus (HBV)–positive grafts and the outcomes of recipients undergoing OLT with HBV‐positive grafts.

Subscribe to